New drug BCD101 put to the test in healthy people first
Knowledge-focused
Recruiting now
This early-stage study is testing a new drug called BCD101 in 56 healthy adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and measure drug levels in the blood. This stu…
Phase: PHASE1 • Sponsor: Bichedam Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC